Biological and Pharmaceutical Bulletin
Online ISSN : 1347-5215
Print ISSN : 0918-6158
ISSN-L : 0918-6158
Notes
OK205 Regulates Production of Inflammatory Cytokines in HMC-1 Cells
In-Young ChoiHyuk-Sang JungHyung-Ryong KimEon-Jeong LeeEun-Hee LeeTae-Yong ShinHyung-Min KimSeung-Heon Hong
Author information
JOURNAL FREE ACCESS

2004 Volume 27 Issue 11 Pages 1871-1874

Details
Abstract

OK205 is a traditional Korean prescription containing water-soluble chitosan, glucosamine HCl, chondroitin sulfate, and extract of herbal medicine, and has been used commercially to treat rheumatoid arthritis (RA). Because infiltrated mast cells and their mediators may contribute to the initiation and progression of the inflammatory process and matrix degradation of RA, we tested the inhibitory effects of OK205 on cytokine production in a human mast cell line (HMC-1 cells). Production of tumor necrosis factor-α was significantly decreased to 0.091±0.010 ng/ml after treatment of HMC-1 cells with OK205 100 μg/ml. The inhibition rate was about 43.57%. In addition, production of interleukin-6 in OK205 1 pg/ml-treated cells was 2.779±0.071 ng/ml, and the inhibition rate was about 50.22%. However, OK205 did not significantly inhibit the production of interleukin-8. These findings may help in understanding the mechanism of action of OK205, leading to control of mast cells in inflammatory conditions like RA.

Content from these authors
© 2004 The Pharmaceutical Society of Japan
Previous article Next article
feedback
Top